Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05998330 · ClinicalTrials.gov registry record · NA
LiverPAL: A Trial of Inpatient Palliative Care for Patients With Advanced Liver Disease
A NA study of Cirrhosis and Cirrhosis, Liver, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT05998330 is a NA study of Cirrhosis and Cirrhosis, Liver that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 200 participants, below the 90,405-participant average among 53 other Cirrhosis trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05998330, a NA study of Cirrhosis and Cirrhosis, Liver, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to evaluate whether early integration of palliative care in the care of hospitalized patients with advanced liver disease (AdvLD) can improve patients' quality of life, physical symptoms, mood, and serious illness communication. Palliative care is a medical specialty focused on lessening (or "palliating") symptoms and assisting in coping with serious illness.
Conditions Studied
Interventions
- BEHAVIORAL LiverPAL
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-09-20 |
| Est. Completion | 2027-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05998330
The ClinicalTrials.gov registry entry for NCT05998330 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 90,405-participant average among 53 other Cirrhosis trials with a reported enrollment target (100% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Cirrhosis appearing as the primary indexed condition, and to 1 intervention - of which LiverPAL is the first listed.
NCT05998330 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05998330 about?
NCT05998330 is a clinical study titled "LiverPAL: A Trial of Inpatient Palliative Care for Patients With Advanced Liver Disease". The goal of this clinical trial is to evaluate whether early integration of palliative care in the care of hospitalized patients with advanced liver disease (AdvLD) can improve patients' quality of life, physical symptoms, mood, and serious illness communication. Palliative care is a medical special...
What is the current status of trial NCT05998330?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2023-09-20. Estimated completion is 2027-07.
What conditions does trial NCT05998330 study?
This clinical trial studies the following conditions: Cirrhosis, Cirrhosis, Liver, End Stage Liver DIsease, Liver Disease Chronic, Advanced Cirrhosis.
What interventions are being tested in trial NCT05998330?
The interventions under investigation include: LiverPAL (BEHAVIORAL).
Who is sponsoring clinical trial NCT05998330?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05998330 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cirrhosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
LiverSleep: A Behavioral Sleep Intervention for Patients With Cirrhosis and Insomnia
RECRUITING · NA
-
Copper Supplementation in Cirrhosis
RECRUITING · NA
-
HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease
RECRUITING · NA
-
CirrhosisRx CDS System
RECRUITING · NA
-
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
RECRUITING · NA
-
Microbiome Modulation With Prebiotics in PTSD and Cirrhosis
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.